Two identical series of Wellcome quality control specimens were analysed by different procedures. One series was entered into the laboratory in the same way as patients' specimens while the other was analysed under special favourable conditions. This involved assaying the samples in replicate in different batches, omitting transcription errors and outliers, and placing the sample in a position following a calibration standard or an internal control. It was found that a significantly higher position in overall league ranking was achieved by assaying the control under 'special conditions'.
SUMMARY. Two identical series of Wellcome quality control specimens were analysed by different procedures. One series was entered into the laboratory in the same way as patients' specimens while the other was analysed under special favourable conditions. This involved assaying the samples in replicate in different batches, omitting transcription errors and outliers, and placing the sample in a position following a calibration standard or an internal control. It was found that a significantly higher position in overall league ranking was achieved by assaying the control under 'special conditions'.
An internal quality control programme plays an extremely important part in assessing intralaboratory performance by giving the laboratory immediate confidence in the results it produces. Participation in external assessment schemes is essential to enable laboratories to compare their results with others using identical chemistries and instrumentation, and to ensure that optimum analytical performance is being reached. This has revolutionised laboratory performance in many parts of the world. 1 External q uality assessment schemes should be used to complement, not to replace, the internal programme and have a vital role to play in the assessment of interlaboratory performance.
We suspect that some laboratories assess their performance by their league table ranking in the Wellcome Quality Control Programme (Wellcome Reagents Limited, Hither Green Lane, London) and analyse their external samples in replicate in order to achieve better results and an elevated position, rather than gaining knowledge ofreal day-to-day performance. The implication of treating these specimens under 'special conditions' has therefore been studied during two 6-month Wellcomecycles (ApriI1981-September 1981 and October 1981~April 1982 ,comparing results from 'blind' quality assurance specimens with those identified and treated as special samples.
Procedure
Wellcome Reagents Limited assigned two separate 64 code numbers to the laboratory identified as X and Y.
Each sample under the X code number was entered into the laboratory as a patient's specimen complete with a fictitious patient request card, and the criteria for accepting the results was as for patient results. The purpose of the study and the distribution of these samples was known only to senior staff of the department.
Each sample under the Ycode number was distributed with the internal controls and intentionally placed following either a calibration standard or an internal control specimen. The sample was analysed in two separate batches, and the mean of the two results was returned to Wellcome. If the two results showed a discrepancy of greater than two standard deviations (as defined by the laboratory internal quality control programme) for a particular test, a third analysis was carried out, the aberrant result was discarded and the mean value of the two remaining results reported. Table I shows the tests for which results were returned indicating the instrumentation and chemistries used.
Results and discussion
Fortnightly reports from Wellcome Reagents Limited for each of the code numbers were examined and the deviation of the individual values from the method mean for each of the tests was noted. Results greater than two standard deviations from the method mean were investigated, revealing that there were several problems within the laboratory that the internal quality control programme could not identify. These included two transcription errors and the reporting of a result fromonesamplewhich was insufficient for analysis. Table 2 shows the number of results within defined standard deviation bands for each 6-month cycle. Statistical analysis of data ( Table 2) showed that for the whole period of study, the number of events in each standard deviation band for X and Y was significantly different (chi-square test, P < 0'001).
Only 6% and 10% of the results for the controls analysed under 'special conditions' (Y)were greater than one standard deviation from the assigned mean for cycle I and 2 respectively, whereas the corresponding figures for the controls treated as patients' specimens (X) were 12% and 19% respectively. Six-monthly end-of-cycle reports displaying histograms of bias and precision for each test were also examined. Table 3 shows the data for each analyte ; entries X and Yare included for both cycles studied. League tables included in the endof-cycle report are primarily based on precision, although bias data is also included. Individual ranking for each test, overall United Kingdom ranking and overall International ranking are T ABLL 2. Total number of results obtained in each defined standard deviation band per 6-month cycle. X = sample treated as patient specimen. Y = sample identified as external quality assurance control No. of standard deviations from assigned value presented. The results confirmed that a small difference in precision values may result in a large difference in individual ranking for particular tests (Table 4 ). The intralaboratory analytical and instrumentation performance of each assay was similar for the two controls, X and Y, as they were analysed over the same period of time. However the overall United Kingdom and International 'league' ranking on both cycles (April 1981 -September 1981 and October 1981 -April 1982 , produced considerably higher positions for those samples which were analysed under 'special conditions' (Table 5 ).
Rumley and Roberts 2 concluded from their study that replication of analysis, elimination of outliers and favourable positioning of quality assessment samples in an analytical run did not materially improve overall position in the Wellcome League ranking. We were unable to confirm their concl usions. Reasons for our findings included: first, the samples analysed in duplicate gave improved precision with values closer to the mean (Table 2) ; second, transcription errors and outliers were eliminated; and third, errors due to carry-over were reduced. Our conclusions Were identical on two separate 6-monthly cycles and therefore cannot be considered to be anomalous or due to chance.
There are a number of external quality assessment schemes covering a wide range of analyses available to the laboratory. Although the presentation of data may differ, the organisers of each of these schemes are agreed in their insistence that the samples must be treated as if they were routine clinical specimens and acceptance of results should be based upon the routine criteria for accepting patients' results. In our opinion, adherence to this recommendation is essential to obtain meaningful information from these schemes. However, some believe that analysing external assessment samples using favourable conditions gives a true indication of assay performance. We would argue that this is the function of an internal quality control programme. The major value of assaying external controls as if they are patients' specimens is that checks are made of the whole laboratory system and if any problems are discovered, the relevant section may be investigated. There is no benefit, especially to the patient, if external controls are analysed favourably. Problems such as deteriorating equipment may be masked and the eventual solution delayed. In addition, an opportunity to assess the incidence of transcription and transposition errors will be lost.
The Wellcome 'league' ranking system will assess the true performance of a laboratory only if all participants adopt common quality control methods. We have demonstrated that laboratories which analyse their external control specimens under 'special conditions' can falsely elevate their league position. These performance indices will therefore be of value only if laboratories carry out the assessment of external controls by methods recommended by the organisers. 
